Novartis Reports Positive Phase III STEER Study Results for OAV101 IT in SMA Type 2 Patients
Digital Pathology Biomarkers: Transforming Precision Oncology Diagnostics and Treatment
DATROWAY® Approved in Japan for HR Positive, HER2 Negative Breast Cancer
FDA Approves Injectable Form of Opdivo, Offering Greater Convenience for Cancer Patients
Reliance Acquires Oncology Platform Karkinos for ₹375 Crore
FDA Approves TEVIMBRA® for First-Line Treatment of PD-L1-Positive Gastric and Gastroesophageal Junction Cancers
CSIR's 2024 Healthcare Breakthroughs: Advancing Cancer Detection, Genetic Disorders, and Neurodegenerative Disease Research
Dr. Sandip Shah Appointed Chairman of NABL: A Visionary Leader in Indian Healthcare
Global and Indian Genetic Testing Market Trends in 2025
Mankind Pharma and Innovent Biologics Partner to Launch Groundbreaking PD-1 Immunotherapy in India
Duchenne Muscular Dystrophy: Diagnosis, Treatment, and Emerging Therapies
Ikena Oncology and Inmagene Biopharmaceuticals Announce Merger to Form ImageneBio
Fujirebio and Eisai Partner to Advance Diagnostics for Neurodegenerative Diseases
European Commission Approves Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H or dMMR mCRC
Deerfield Management to Acquire Singular Genomics for $20 Per Share in All-Cash Deal